A Study on Vitamin D and Cathelicidin Status in Patients with Rosacea: Serum Level and Tissue Expression

키워드

참고문헌 (24)

1. Yamasaki K, "Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea", Nat Med, 13, pp.975~980 (2007)[DOI]
2. Gombart AF, "Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3", FASEB J, 19, pp.1067~1077 (2005)[DOI]
3. Schauber J, "The vitamin D pathway: a new target for control of the skin's immune response?", Exp Dermatol, 17, pp.633~639 (2008)[DOI]
4. Two AM, "Introduction, categorization, histology, pathogenesis, and risk factors", J Am Acad Dermatol, 72, pp.749~758 (2015)[DOI]
5. Wilkin J, "Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea", J Am Acad Dermatol, 46, pp.584~587 (2002)[DOI]
6. Chaiyarit P, "Oral lichen planus: an immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis", J Oral Pathol Med, 28, pp.210~215 (1999)
7. Gennaro R, "Structural features and biological activities of the cathelicidin-derived antimicrobial peptides", Biopolymers, 55, pp.31~49 (2000)[DOI]
8. Braff MH, "Antimicrobial peptides: an essential component of the skin defensive barrier", Curr Top Microbiol Immunol, 306, pp.91~110 (2006)
9. Braff MH, "Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities", J Immunol, 174, pp.4271~4278 (2005)[DOI]
10. Koczulla R, "An angiogenic role for the human peptide antibiotic LL-37", hCAP-18, 2003, pp.111, 1665~1672
11. Mookherjee N, "Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37", J Immunol, 176, pp.2455~2464 (2006)[DOI]
12. Steinhoff M, "New insights into rosacea pathophysiology: a review of recent findings", J Am Acad Dermatol, 69(6 Suppl 1), pp.S15~S26 (2013)[DOI]
13. Linde A, "Clinical relevance of cathelicidin in infectious disease", J Clin Cell Immunol, S13, pp.003~ (2013)
14. Kanda N, "Increased serum leucine, leucine-37 levels in psoriasis: positive and negative feedback loops of leucine, leucine-37 and pro- or anti-inflammatory cytokines", Hum Immunol, 71, pp.1161~1171 (2010)[DOI]
15. Kanda N, "Increased serum human <TEX>${\beta}$<", TEX>-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M, 2012, pp.217, 436~445
16. Yamasaki K, "TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes", J Invest Dermatol, 131, pp.688~697 (2011)[DOI]
17. Yamasaki K, "Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin", FASEB J, 20, pp.2068~2080 (2006)[DOI]
18. Yamasaki K, "Rosacea as a disease of cathelicidins and skin innate immunity", J Investig Dermatol Symp Proc, 15, pp.12~15 (2011)[DOI]
19. Liu PT, "Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response", Science, 311, pp.1770~1773 (2006)[DOI]
20. Ekiz O, "Vitamin D status in patients with rosacea", Cutan Ocul Toxicol, 33, pp.60~62 (2014)[DOI]
21. Hata TR, "Administration of oral vitamin D induces cathelicidin production in atopic individuals", J Allergy Clin Immunol, 122, pp.829~831 (2008)[DOI]
22. Park K, "Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway", J Biol Chem, 286, pp.34121~34130 (2011)[DOI]
23. Duman N, "Rosacea and cardiovascular risk factors: a case control study", J Eur Acad Dermatol Venereol, 28, pp.1165~1169 (2014)[DOI]
24. Akin Belli A, "The relationship between rosacea and insulin resistance and metabolic syndrome", Eur J Dermatol, 26, pp.260~264 (2016)

관련 논문AI추천